Iovance Biotherapeutics (IOVA) price targets raised following FDA accelerated approval

Go back to Iovance Biotherapeutics (IOVA) price targets raised following FDA accelerated approval

Form 8-K IOVANCE BIOTHERAPEUTICS, For: Feb 16

February 20, 2024 6:05 AM EST

false 0001425205 0001425205 2024-02-16 2024-02-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares... More